Results 181 to 190 of about 54,034 (217)
Some of the next articles are maybe not open access.
Drug resistance in Cryptococcus neoformans
Drug Resistance Updates, 1999Cryptococcus neoformans has become a major opportunistic fungal pathogen worldwide. Successful treatment of invasive disease with this fungus has used amphotericin B, flucytosine and various azoles. However, treatment failures continue to occur for a variety of reasons including direct antifungal drug resistance.
John R., Perfect, Gary M., Cox
openaire +2 more sources
Phospholipase activity in Cryptococcus neoformans
Mycopathologia, 1996Phospholipases have only been detected in a few fungi and yeasts, in particular in Candida albicans. Secreted phospholipases are considered by some researchers to be a potential factor of virulence and pathogenicity in C. albicans. Twenty-three Cryptococcus neoformans strains were tested in order to observe phospholipase production.
V, Vidotto +5 more
openaire +2 more sources
Canadian journal of medical technology, 1998
Arturo Casadevall, John R. Perfect
openaire +3 more sources
Arturo Casadevall, John R. Perfect
openaire +3 more sources
Treatment strategies for cryptococcal infection: challenges, advances and future outlook
Nature Reviews Microbiology, 2021Ci Fu, Nicole Robbins, Leah E Cowen
exaly
ISOLATION OF CRYPTOCOCCUS NEOFORMANS
The Lancet, 1982D R, McCluskey +2 more
openaire +2 more sources